ADR Biomedical Holdings (TSE:3750) Institutional Ownership: 0.19% (As of Aug. 12, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:3750 ADR Biomedical Holdings Inc TSE:3750
28 GF Score
Price 円792.00
GF Value 円39.51
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is ADR Biomedical Holdings Institutional Ownership?

ADR Biomedical Holdings TSE:3750 28 Institutional Ownership is 0.19% as of Aug. 12, 2026. GuruFocus rates TSE:3750 with a GF Score™ of 28/100 and a GF Value™ of 円39.51 (Significantly Overvalued). The stock has 8 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, ADR Biomedical Holdings's institutional ownership is 0.19%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, ADR Biomedical Holdings's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, ADR Biomedical Holdings's Float Percentage Of Total Shares Outstanding is 0.00%.

ADR Biomedical Holdings Institutional Ownership Historical Data

* Premium members only.

The historical data trend for ADR Biomedical Holdings's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ADR Biomedical Holdings Institutional Ownership Chart

ADR Biomedical Holdings Historical Data

The historical data trend for ADR Biomedical Holdings can be seen below:

2015-06-30 2015-07-31 2015-08-31 2015-09-30 2015-10-31 2015-11-30 2015-12-31 2016-01-31 2016-02-29 2016-03-31
Institutional Ownership 6.47 6.47 6.47 6.47 0.96 0.19 0.19 0.19 0.19 0.19
TSE:3750
28GF Score
ADR Biomedical Holdings Inc TSE:3750
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ADR Biomedical Holdings Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 0.19% mean?
ADR Biomedical Holdings (TSE:3750) has a Institutional Ownership of 0.19% as of Aug. 12, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on ADR Biomedical Holdings and its competitors.
Is ADR Biomedical Holdings' Institutional Ownership too high?
ADR Biomedical Holdings' current Institutional Ownership is 0.19%. Overall, ADR Biomedical Holdings has a GF Score™ of 28/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does ADR Biomedical Holdings' Institutional Ownership compare to VRTX and REGN?
ADR Biomedical Holdings' Institutional Ownership of 0.19% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on ADR Biomedical Holdings and its competitors. ADR Biomedical Holdings's current Institutional Ownership is 0.19%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ADR Biomedical Holdings stock overvalued right now?
Based on GuruFocus' analysis, ADR Biomedical Holdings (TSE:3750) is currently considered Significantly Overvalued. The stock's GF Value™ is 円39.51, compared to a current price of 円792.00 — trading 1904.6% above its estimated fair value. The current Institutional Ownership is 0.19%. ADR Biomedical Holdings' overall GF Score™ is 28/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For ADR Biomedical Holdings (TSE:3750), the current Institutional Ownership is 0.19% as of Aug. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is ADR Biomedical Holdings (TSE:3750) Overvalued in 2026?

Based on GuruFocus' analysis, ADR Biomedical Holdings stock appears to be overvalued. The current stock price of 円792.00 is trading 1904.6% above its estimated GF Value™ of 円39.51. GuruFocus considers ADR Biomedical Holdings to be Significantly Overvalued.

Key valuation signals for TSE:3750:

  • Institutional Ownership: 0.19%
  • GF Value™: 円39.51 vs. price of 円792.00 (1904.6% above fair value)
  • GF Score™: 28/100 with 8 warning signs

No single metric tells the full story. See the TSE:3750 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

ADR Biomedical Holdings Business Description

Address 1-1-1 Otemachi, Otemachi Park Building, Chiyoda-ku, Tokyo, JPN, 100-0004
ADR120S Inc developing a new clinical approach to cell therapy to provide medical care to patients by providing medical care that responds to unmet medical needs based on its regenerative medicine. Its product pipeline includes Habeo; ECCO-50 and others.
28GF Score

Get the complete analysis for TSE:3750

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円792.00
Price
円39.51
GF Value